Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-27 Sale | 2022-06-01 4:20 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,382 | $10.07 | $13,917 | 258,747 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 4:28 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 8,002 | $10.45 | $83,621 | 276,037 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 4:27 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 4,632 | $10.45 | $48,404 | 260,129 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 4:25 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 7,049 | $10.45 | $73,662 | 174,953 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 4:25 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 24,594 | $10.45 | $257,007 | 447,956 (Direct) | View |
| 2022-04-05 Sale | 2022-04-07 4:19 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 2,436 | $13.78 | $33,568 | 172,928 (Direct) | View |
| 2022-04-05 Sale | 2022-04-07 4:16 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,922 | $13.78 | $26,485 | 161,058 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:54 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,362 | $13.35 | $18,183 | 162,980 (Direct) | View |
| 2022-01-19 Sale | 2022-01-21 4:08 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 19,882 | $14.68 | $291,868 | 337,983 (Direct) | View |
| 2022-01-04 Sale | 2022-01-06 4:46 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 4,475 | $16.27 | $72,808 | 175,364 (Direct) | View |
| 2022-01-04 Sale | 2022-01-06 4:21 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 2,271 | $16.27 | $36,949 | 164,342 (Direct) | View |
| 2021-11-29 Sale | 2021-12-01 4:10 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,978 | $19.3 | $38,175 | 166,613 (Direct) | View |
| 2021-11-03 Sale | 2021-11-05 4:27 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 3,800 | $24.02 | $91,262 | 482,291 (Direct) | View |
| 2021-10-05 Sale | 2021-10-07 4:03 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 2,738 | $21.62 | $59,196 | 168,591 (Direct) | View |
| 2021-10-05 Sale | 2021-10-07 4:02 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 6,671 | $21.62 | $144,227 | 179,839 (Direct) | View |
| 2021-09-28 Purchase | 2021-09-30 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 20,677 | $22.85 | $472,383 | 50,041,181 (Indirect) | View |
| 2021-09-27 Sale | 2021-09-29 4:12 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 7,000 | $24.32 | $170,240 | 330,429 (Direct) | View |
| 2021-09-24 Purchase | 2021-09-28 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 84,000 | $23.87 | $2,004,937 | 50,020,504 (Indirect) | View |
| 2021-09-22 Purchase | 2021-09-24 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 138,796 | $22.39 | $3,108,226 | 49,936,504 (Indirect) | View |
| 2021-09-20 Purchase | 2021-09-22 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 81,273 | $22.3 | $1,812,120 | 49,797,708 (Indirect) | View |
| 2021-09-16 Purchase | 2021-09-20 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 87,913 | $22.2 | $1,951,656 | 49,716,435 (Indirect) | View |
| 2021-09-14 Purchase | 2021-09-16 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 161,164 | $22.03 | $3,551,175 | 49,628,522 (Indirect) | View |
| 2021-09-10 Purchase | 2021-09-14 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 113,178 | $23.84 | $2,698,439 | 49,467,358 (Indirect) | View |
| 2021-09-09 Sale | 2021-09-13 4:11 pm | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 4,850 | $25.58 | $124,063 | 5,250 (Direct) | View |
| 2021-09-08 Purchase | 2021-09-10 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 58,902 | $25.6 | $1,507,811 | 49,354,180 (Indirect) | View |
| 2021-09-03 Purchase | 2021-09-08 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 64,400 | $26.49 | $1,705,923 | 49,295,278 (Indirect) | View |
| 2021-09-01 Purchase | 2021-09-03 5:00 pm | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner | 103,102 | $25.6 | $2,638,921 | 49,230,878 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-15 Option Award | 2022-04-19 4:52 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Mehra Uneek Principal Financial Officer | 111,111 | $0 | 214,180 (Direct) | View |
| 2022-04-15 Option Award | 2022-04-19 4:51 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 103,703 | $0 | 264,761 (Direct) | View |
| 2022-04-15 Option Award | 2022-04-19 4:49 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 111,111 | $0 | 284,039 (Direct) | View |
| 2022-04-15 Option Award | 2022-04-19 4:48 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 103,703 | $0 | 182,002 (Direct) | View |
| 2022-04-15 Option Award | 2022-04-19 4:46 pm | N/A 2032-04-14 | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 339,375 | $0 | 677,358 (Direct) | View |
| 2021-11-05 Option Award | 2021-11-09 5:40 pm | N/A 2031-11-04 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 21,096 | $0 | 21,096 (Direct) | View |
| 2021-11-05 Option Award | 2021-11-09 5:38 pm | N/A 2031-11-04 | Myovant Sciences Ltd. | MYOV | GUINAN MARK Director | 21,096 | $0 | 21,096 (Direct) | View |
| 2021-11-05 Option Award | 2021-11-09 5:36 pm | N/A 2031-11-04 | Myovant Sciences Ltd. | MYOV | Gulfo Adele M. Director | 21,096 | $0 | 21,096 (Direct) | View |
| 2021-11-05 Option Award | 2021-11-09 5:26 pm | N/A 2031-11-04 | Myovant Sciences Ltd. | MYOV | POTTER MYRTLE S Director | 21,096 | $0 | 21,096 (Direct) | View |
| 2021-11-05 Option Award | 2021-11-09 5:15 pm | N/A 2031-11-04 | Myovant Sciences Ltd. | MYOV | Valente Nancy Director | 36,892 | $0 | 36,892 (Direct) | View |
| 2021-11-05 Ownership | 2021-11-09 5:13 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Valente Nancy Director | 0 | $0 | 0 (Direct) | View |
| 2021-11-03 Exercise | 2021-11-05 4:27 pm | N/A 2027-08-14 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 3,800 | $0 | 482,291 (Direct) | View |
| 2021-11-03 Exercise | 2021-11-05 4:27 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 3,800 | $7.78 | 482,291 (Direct) | View |
| 2021-09-27 Exercise | 2021-09-29 4:12 pm | N/A 2027-08-14 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 7,000 | $0 | 330,429 (Direct) | View |
| 2021-09-27 Exercise | 2021-09-29 4:12 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 7,000 | $7.78 | 330,429 (Direct) | View |
| 2021-09-15 Option Award | 2021-09-17 4:31 pm | N/A 2031-09-14 | Myovant Sciences Ltd. | MYOV | Mehra Uneek Principal Financial Officer | 268,261 | $0 | 268,261 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 4:11 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 4,850 | $7.65 | 5,250 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 4:11 pm | N/A 2029-08-23 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 4,850 | $0 | 5,250 (Direct) | View |
| 2021-09-07 Ownership | 2021-09-09 4:24 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Mehra Uneek Principal Financial Officer | 0 | $0 | 0 (Direct) | View |